BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26657980)

  • 21. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medication.
    von Scholten BJ; Ørsted DD; Svendsen AL; Persson F; Rossing P
    J Diabetes Complications; 2015; 29(8):1146-51. PubMed ID: 26345339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study.
    Maple-Brown LJ; Ekinci EI; Hughes JT; Chatfield M; Lawton PD; Jones GR; Ellis AG; Sinha A; Cass A; Hoy WE; O'Dea K; Jerums G; MacIsaac RJ;
    Diabet Med; 2014 Jul; 31(7):829-38. PubMed ID: 24598003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
    Mitchell T; Hadlow N; Chakera A
    Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease.
    Crawford A; Fassett RG; Coombes JS; Kunde DA; Ahuja KD; Robertson IK; Ball MJ; Geraghty DP
    Nephrol Dial Transplant; 2011 Sep; 26(9):2806-13. PubMed ID: 21325350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT).
    Earle KA; Zitouni K; Pepe J; Karaflou M; Godbold J
    J Transl Med; 2016 Aug; 14(1):234. PubMed ID: 27492324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Plasma Hydrogen Sulfide Is Associated with Impaired Renal Function and Cardiac Dysfunction.
    Kuang Q; Xue N; Chen J; Shen Z; Cui X; Fang Y; Ding X
    Am J Nephrol; 2018; 47(5):361-371. PubMed ID: 29779029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia.
    Tanaka K; Hara S; Kushiyama A; Ubara Y; Yoshida Y; Mizuiri S; Aikawa A; Kawatzu S
    Clin Exp Nephrol; 2011 Jun; 15(3):391-397. PubMed ID: 21331740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal elimination of sclerostin increases with declining kidney function.
    Cejka D; Marculescu R; Kozakowski N; Plischke M; Reiter T; Gessl A; Haas M
    J Clin Endocrinol Metab; 2014 Jan; 99(1):248-55. PubMed ID: 24187403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels and dietary intake of minerals in patients with type 2 diabetes and chronic kidney disease: A case-control study.
    Sivaprasad M; Shalini T; Sahay M; Sahay R; Satyanarayanan M; Reddy GB
    J Trace Elem Med Biol; 2024 Jul; 84():127425. PubMed ID: 38484635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
    Ferrari P; Xiao J; Ukich A; Irish A
    Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease.
    Gugliucci A; Menini T
    Adv Exp Med Biol; 2014; 824():191-208. PubMed ID: 25039001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
    Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
    Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between IDMS-traceable Jaffe and enzymatic creatinine assays for estimation of glomerular filtration rate by the CKD-EPI equation in healthy and diabetic subjects.
    Cheuiche AV; Soares AA; Camargo EG; Weinert LS; Camargo JL; Silveiro SP
    Clin Biochem; 2013 Oct; 46(15):1423-9. PubMed ID: 23747959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.